Highly unlikely to be able to file on just the data being presented from a single arm single site, even if there are some responses (especially if those responses are in the chemo arm)
You're not making sense here or maybe I just don't understand the point you are trying to make.
But aside from that I do believe that it is possible to file for pancreatic based on these data with supportive safety data from other indications.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.